Celcuity (CELC)
(Delayed Data from NSDQ)
$70.57 USD
+0.53 (0.76%)
Updated Oct 23, 2025 04:00 PM ET
After-Market: $70.53 -0.04 (-0.06%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth C Momentum F VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
CELC 70.57 +0.53(0.76%)
Will CELC be a Portfolio Killer in October?
Zacks Investment Research is releasing its prediction for CELC based on the 1-3 month trading system that more than doubles the S&P 500.

Other News for CELC
180 Bullish Setup appears for CELC after 6.93% move
Celcuity (CELC): HC Wainwright Raises Price Target to $77, Reaffirms Buy Rating | CELC Stock News
Is CELC signaling a buying opportunity? Slingshot Bullish shows up after tumbling 7.2%
Analysts Offer Insights on Healthcare Companies: Celcuity (CELC) and Viridian Therapeutics (VRDN)
Celcuity price target raised to $77 from $66 at H.C. Wainwright